Edition:
United States

Threshold Pharmaceuticals Inc (THLD.OQ)

THLD.OQ on NASDAQ Stock Exchange Capital Market

0.90USD
26 Aug 2016
Change (% chg)

$0.01 (+0.57%)
Prev Close
$0.90
Open
$0.90
Day's High
$0.92
Day's Low
$0.89
Volume
92,007
Avg. Vol
285,793
52-wk High
$5.28
52-wk Low
$0.21

THLD.OQ

Chart for THLD.OQ

About

Threshold Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of therapeutic and diagnostic agents that selectively target tumor cells for the treatment of patients living with cancer. It is developing two therapeutic product candidates based on hypoxia-activat... (more)

Overall

Beta: 3.64
Market Cap(Mil.): $64.35
Shares Outstanding(Mil.): 71.51
Dividend: --
Yield (%): --

Financials

  THLD.OQ Industry Sector
P/E (TTM): 1.70 37.73 37.01
EPS (TTM): 0.53 -- --
ROI: 123.39 0.17 14.15
ROE: 6,428.33 -1.96 15.06

BRIEF-Threshold Pharmaceuticals Q2 loss per share $0.10

* Threshold Pharmaceuticals reports second quarter financial results

Aug 01 2016

BRIEF-Threshold Pharmaceuticals says received preliminary comments from FDA

* On June 2, received preliminary comments from FDA relating to co' s request for a meeting Source text: (http://1.usa.gov/22ICDdw) Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Jun 06 2016

BRIEF-Threshold Pharmaceuticals Q1 revenue $110 mln

* Threshold Pharmaceuticals reports first quarter financial results

May 05 2016

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : GlobalData
$300.00
Provider : S&P Capital IQ Quantitative Report
$115.00
Provider : Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.